Clinical Trial Update: Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of neoadjuvant immunochemotherapy in elderly patients with resectable esophageal cancer; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING